 JAMA 1995;274:
155-60.
131. Fiore MC, Bailey WC, Cohen SJ, et al. Smoking cessation. Clinical
Practice Guideline No. Rockville, MD: Department of Health and
Human Services, Public Health Service, Agency for Health Care
Policy and Research; 1996, p. 18. AHCPR Publication 96-0692.
132. Frank E, Winkleby MA, Altman DG, Rockhill B, Fortmann SP.
Predictors of physician’s smoking cessation advice. JAMA 1991;266:
3139-44.
133. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of the
nicotine patch for smoking cessation. A meta-analysis. JAMA 1994;
271:1940-7.
134. Wolff T, Miller T, Ko S. Aspirin for the primary prevention of
cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2009;150:405-10.
135. Pearson TA, Blair SN, Daniels SR, Eckel RH, Fair JM, Fortmann SP,
et al. AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients without Coronary or
other atherosclerotic Vascular Diseases. American Heart Association
Science Advisory and Coordinating Committee. Circulation 2002;
106:388-91.
136. Antithrombotic Trialists’ Collaboration. Collaborative meta-analysis
of randomised trials of antiplatelet therapy for prevention of death,
myocardial infarction, and stroke in high risk patients. BMJ 2002;324:
71-86.
137. Albers GW, Amarenco P, Easton JD, Sacco RL, Teal P, et al. Antithrombotic and thrombolytic therapy for ischemic stroke: American
College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 20